What drove the pre-market move in 6L9.F stock today?

The pre‑market move to **€0.025** was driven by a surge in volume to **3,500** vs. average **279**. Low float and thin order books on XETRA amplify small trades into large percentage moves. Check company news and order flow for confirmation.

How does Meyka AI grade 6L9.F stock and what does it mean?

Meyka AI rates 6L9.F **57.47/100 (C+, HOLD)**. The grade combines benchmark, sector, growth, key metrics and analyst factors. It signals caution, not a buy or sell order, and is for informational use only.

What is Meyka AI's forecast and implied upside for 6L9.F stock?

Meyka AI's forecast model projects **€0.10** for 6L9.F in 12 months. Versus the current **€0.025**, that implies an upside of **300.00%**. Forecasts are projections and not guarantees; manage risk accordingly.

Should traders use market or limit orders for 6L9.F stock?

Use limit orders. Thin liquidity and wide spreads on XETRA can create poor execution with market orders. Limit orders reduce slippage but may not fill in fast moves.

DE Stocks

Pre-market high-volume: 6L9.F ViewRay (XETRA) €0.03 03 Feb 2026, watch liquidity

ByHuzaifa Zahoor February 3, 2026February 3, 2026

Pre-market activity shows 6L9.F stock trading at €0.025 on XETRA in Germany on 03 Feb 2026, after a sharp intraday move from the prior close of €0.001. Volume surged to 3,500 shares versus an average of 279, giving a relative volume of 12.54. The combination of extreme volume and a 1‑month change of +2400.00% makes 6L9.F a clear high-volume mover in the healthcare medical‑devices segment this morning.